From: Impact of delays in radiotherapy of head and neck cancer on outcome
Characteristics | No. (%) |
---|---|
Gender | |
Female | 9 (20%) |
Male | 36 (80%) |
Age (years)a) | 60.47 (43.5–81.5) |
Tumor locationb) | |
Oropharynx | 35 (61.4%) |
Hypopharynx | 3 (5.3%) |
Larynx | 19 (33.3%) |
Stageb) | |
Stage I | 5 (8.8%) |
Stage II | 2 (3.5%) |
Stage III | 14 (24.6%) |
Stage IV | 36 (63.2%) |
Therapyb) | |
Radiotherapy | 9 (20%) |
Concurrent chemoradiotherapy | 36 (80%) |
Tumor volume relative increase rate (%/day)a) | 1.03 (0.99–1.41) |
Tumor volume doubling time (days)a) | 19 (2–659) |